v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (46,673) $ (47,429)
Less: net income from discontinued operations, net of income taxes 0 (2,148)
Net loss from continuing operations (46,673) (49,577)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 14,120 14,302
Stock-based compensation 3,453 3,593
Non-cash interest expense 2,507 2,833
Deferred income taxes (315) (2,464)
Provision for credit losses 668 548
Reduction in carrying amount of operating lease right-of-use assets 489 237
Change in fair value of earnout receivable (784)  
Changes in operating assets and liabilities:    
Accounts receivable (530) 3,339
Prepaid expenses and other current assets 815 2,065
Other assets (11) 30
Accounts payable 3,570 (7,738)
Deferred revenue 289 653
Accrued expenses and other current liabilities (2,797) 500
Other non-current liabilities (78) 341
Net cash used in operating activities - continuing operations (25,277) (31,338)
Net cash provided by operating activities - discontinued operations   3,547
Net cash used in operating activities (25,277) (27,791)
Cash flows from investing activities:    
Capital expenditures (2,311) (3,247)
Sale of non-marketable equity investment   1,800
Net cash used in investing activities - continuing operations (2,311) (1,447)
Net cash used in investing activities - discontinued operations   (152)
Net cash used in investing activities (2,311) (1,599)
Cash flows from financing activities:    
Repayment of senior secured term loan (3,875) (1,938)
Proceeds from issuance of stock and pre-funded warrants under registered direct offerings and at-the-market offering, net of offering costs 29,449  
Debt issuance costs (114)  
Proceeds from issuances of stock under employee stock plans, net 140 235
Taxes paid related to net share settlement of equity awards (341) (456)
Settlement of deferred consideration for acquisitions   (1,800)
Net cash provided by (used in) financing activities - continuing operations 25,259 (3,959)
Net cash provided by financing activities - discontinued operations 0  
Net cash provided by (used in) financing activities 25,259 (3,959)
Effect of exchange rates on cash, cash equivalents, and restricted cash (1,133)  
Net change in cash, cash equivalents, and restricted cash (3,462) (33,349)
Cash, cash equivalents, and restricted cash, beginning of period 17,318 80,306
Cash, cash equivalents, and restricted cash, end of period 13,856 46,957
Less: cash, cash equivalents, restricted cash included in discontinued operations   (39,357)
Cash, cash equivalents, and restricted cash included in continuing operations 13,856 7,600
Non-cash investing and financing activities:    
Stock-based compensation capitalized as part of internal-use software 110 $ 212
Lease liabilities arising from right-of-use assets 1,840  
Shares issued for debt issuance costs 873  
Capital expenditures included in accounts payable $ 496  

Source

10-Q PDF XBRL Zip